EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas

Background: Anti-EGFR antibody therapy is still one of the clinical choices in head and neck squamous cell carcinoma (HNSCC) patients, but the emergence of cetuximab resistance questioned its effectiveness and reduced its applicability. Although several possible reasons of resistance against the ant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pathol Oncol Res
Main Authors: Nelhűbel, Györgyi A., Cserepes, Mihály, Szabó, Balázs, Türk, Dóra, Kárpáti, Adél, Kenessey, István, Rásó, Erzsébet, Barbai, Tamás, Hegedűs, Zita, László, Viktória, Szokol, Bálint, Dobos, Judit, Őrfi, László, Tóvári, József
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Society Journal Archive
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8262169/
https://ncbi.nlm.nih.gov/pubmed/34257586
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/pore.2021.620256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados